Delivery Order SPE2DB20D2104-SPE2DB24FR47Q
- Not listed
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,440.00 and is a firm fixed-price delivery order with a completion date of December 27, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $29,174.58 and is a Firm Fixed Price Delivery Order that runs through September 19, 2023. The award was made without any set-aside designation, indicating full and open competition....
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical, a major medical supply chain organization within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,100.61 with a firm fixed price, and the ultimate...
- This federal contract award is for the delivery of 4566305582 Cyclosporine 0.05% eye emulsion in 60 count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,888.00 and a completion date of November 4, 2024. It is a Delivery Order under a Firm Fixed Price contract type. The contract is not designated with a...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $1,082.76 and a performance period through March 19, 2024. The contract does not have a set-aside designation....
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to support Defense Logistics Agency (DLA) Troop Support Medical operations. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm. The award, valued at $6,320.92, is a firm-fixed price delivery order contract with a completion date of January 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The award, valued at $1,689.99, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with a completion date of November 8, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various federal agencies, with...
- This federal contract award is for the delivery of Cyclosporine 0.05% Eye Emulsion to the Defense Logistics Agency (DLA). The contract, valued at $1,175.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which was previously awarded to Cencora, Inc. and runs through December 2025. This IDC serves as the primary...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $33,806.39 and a completion date of July 20, 2023. It was awarded on July 19, 2023 and is not designated as a set-aside contract....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR47QDelivery Order
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion in 60-count packages to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,008.44 and is a firm fixed-price delivery order with a completion date of December 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/5/23 |